AstraZeneca - Pioneering sustainability across full span of global pharma operations

AstraZeneca - Pioneering sustainability across full span of global pharma operations

With strong commitments and efforts to reduce greenhouse gas emissions globally, AstraZeneca is pioneering the Net-Zero Corporate Standard of the new Science Based Targets initiative in the pharmaceutical industry. Nitin Kapoor, chairman and general director of AstraZeneca Vietnam, discussed with Thuy Nguyen the company’s sustainable development strategy and its contribution to the sustainable growth of healthcare in Vietnam.
Pharma giants beat revenue expectations

Pharma giants beat revenue expectations

Pharmaceutical companies like Pfizer, Novartis, Roche, and GSK performed well in the first three quarters of 2021, with plans to venture further into the lucrative Vietnamese market.
New race begins with COVID-19 oral medications

New race begins with COVID-19 oral medications

Together with vaccines, multinational corporations are on the journey to make oral antiviral medication for the treatment of COVID-19, expecting to bring new innovation for infections and promising profitable years for pharma giants.
Pharma drive a chance for real estate

Pharma drive a chance for real estate

Despite having limited facilities for life sciences real estate, Vietnam could open up to potential development in the industry, analysts say.
More time and effort required for EVFTA-led pharma advances

More time and effort required for EVFTA-led pharma advances

The EU-Vietnam Free Trade Agreement (EVFTA) officially took effect in August 2020, opening tremendous prospects in the comprehensive partnership between the two.
EVFTA effect yet to blossom in pharma

EVFTA effect yet to blossom in pharma

While encouraging signs bring some hope for European players in the enforcement of the EU-Vietnam Free Trade Agreement, more conundrums are still to be solved to increase attraction for the local pharmaceutical market.
Pharma rules unable to stand test of time

Pharma rules unable to stand test of time

After four years of enforcement of certain pharmaceutical rules, multinational corporations remain concerned and are changing operations in Vietnam, with import being one of the main focuses.
Targets being tweaked by prepared pharma

Targets being tweaked by prepared pharma

There remains caution over interruption in the ingredient supply chain in Vietnam’s lucrative pharmaceutical industry, but new strategies to intensify growth potential ahead will ensure pharma groups maintain their profitability moving forward.
Japan’s health names latch onto Vietnam

Japan’s health names latch onto Vietnam

More Japanese pharma and healthcare companies are heading to Vietnam as drug demands in the local lucrative market are on the rise.
Pharma groups redouble patient-centric efforts

Pharma groups redouble patient-centric efforts

Driven by 2020’s highlights, international pharma giants are planning to deliver more vital medicines and vaccines to Vietnam in 2021 to tap into local demands and enable the country to weather future crises.
Promising figures offering confidence for pharma future

Promising figures offering confidence for pharma future

Vietnamese pharmaceutical giants rushed to new business lines in 2020 to create new motivation for growth amid the ongoing pandemic complications, with some changes bringing about better results.
Recall of drug spoils pharma reputation

Recall of drug spoils pharma reputation

Public concerns have ignited over the recall of a popular anti-allergy drug produced by BRV Healthcare, a joint venture between domestic group BV Pharma and UK firm RV Group.
Fresh rules to tackle pharma misconduct

Fresh rules to tackle pharma misconduct

Violations in the pharmaceutical industry are seemingly never-ending, with Young Il Pharm, USV Private, and Armepharco being among recent prominent names. However, future wrongdoings may be better resisted when new stricter rules come into effect next month.
Pharma violators in tender fiasco

Pharma violators in tender fiasco

A number of big pharma companies have been caught violating drug tenders to turn a profit, triggering public concerns over their code of ethics.
Vaccine sales stir big pharma

Vaccine sales stir big pharma

Amidst lower-than-expected business performance, international pharma giants are betting on COVID-19 vaccine sales, hoping to alter the headwinds from the health crisis to their advantage.
1 2 3